Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia

BACKGROUND: Endothelial progenitor cell (EPC) transplantation is a promising therapy for ischemic diseases such as ischemic myocardial infarction and hindlimb ischemia. However, limitation of EPC sources remains a major obstacle. Direct reprogramming has become a powerful tool to produce EPCs from f...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Stem Cell Res Ther
Glavni autori: Van Pham, Phuc, Vu, Ngoc Bich, Nguyen, Hoa Trong, Huynh, Oanh Thuy, Truong, Mai Thi-Hoang
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2016
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4973107/
https://ncbi.nlm.nih.gov/pubmed/27488544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-016-0368-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items